Literature DB >> 16095907

Focal not widespread grafts induce novel dyskinetic behavior in parkinsonian rats.

Eleonora Maries1, Jeffrey H Kordower, Yaping Chu, Timothy J Collier, Caryl E Sortwell, Eliza Olaru, Kathleen Shannon, Kathy Steece-Collier.   

Abstract

Dyskinesias are a common consequence of dopaminergic therapy in patients with Parkinson's disease. Little is known about the influence of cellular replacement strategies upon drug-induced dyskinesias. In the current study, we employed parkinsonian rats to test whether the distribution of dopamine neuron grafts could differentially alter striatal circuitry and levodopa-induced dyskinesias. Specifically, we compared behavioral and neurochemical consequences of dopamine reinnervation restricted to a focal region of the striatum to innervation encompassing the majority of the striatum by distributing the same number of cells into single locus or multiple locations. Both the single-site and widespread grafts reduced pregraft dyskinesias and normalized FosB/DeltaFosB in the dorsal two-thirds of the lateral striatum. However, single-site DA graft recipients developed a robust, novel forelimb-facial stereotypy and upregulated FosB/DeltaFosB expression in the ventrolateral striatum, an area associated with movements of tongue and forelimbs. The onset of forelimb-facial stereotypy correlated with measures of increased graft function.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16095907     DOI: 10.1016/j.nbd.2005.07.002

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  34 in total

1.  Proceedings: cell therapies for Parkinson's disease from discovery to clinic.

Authors:  Rosa Canet-Aviles; Geoffrey P Lomax; Ellen G Feigal; Catherine Priest
Journal:  Stem Cells Transl Med       Date:  2014-08-22       Impact factor: 6.940

2.  Effects of ex vivo transduction of mesencephalic reaggregates with bcl-2 on grafted dopamine neuron survival.

Authors:  Caryl E Sortwell; William J Bowers; Scott E Counts; Mark R Pitzer; Matthew F Fleming; Susan O McGuire; Kathleen A Maguire-Zeiss; Howard J Federoff; Timothy J Collier
Journal:  Brain Res       Date:  2006-12-28       Impact factor: 3.252

Review 3.  Regulatable promoters and gene therapy for Parkinson's disease: is the only thing to fear, fear itself?

Authors:  Jeffrey H Kordower; C Warren Olanow
Journal:  Exp Neurol       Date:  2007-08-22       Impact factor: 5.330

4.  The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviors.

Authors:  K E Soderstrom; G Meredith; T B Freeman; S O McGuire; T J Collier; C E Sortwell; Qun Wu; K Steece-Collier
Journal:  Neurobiol Dis       Date:  2008-07-11       Impact factor: 5.996

5.  Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism.

Authors:  Daniella Rylander; Vincenza Bagetta; Valentina Pendolino; Elisa Zianni; Shane Grealish; Fabrizio Gardoni; Monica Di Luca; Paolo Calabresi; M Angela Cenci; Barbara Picconi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-29       Impact factor: 11.205

6.  Columnar Injection for Intracerebral Cell Therapy.

Authors:  Jeffrey S Schweitzer; Bin Song; Pierre R Leblanc; Melissa Feitosa; Bob S Carter; Kwang-Soo Kim
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-03-01       Impact factor: 2.703

7.  Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats.

Authors:  Kathy Steece-Collier; Timothy J Collier; Jack W Lipton; Jennifer A Stancati; Mary E Winn; Allyson Cole-Strauss; Rhyomi Sellnow; Melissa M Conti; Natosha M Mercado; Eduardo A Nillni; Caryl E Sortwell; Fredric P Manfredsson; Christopher Bishop
Journal:  Exp Neurol       Date:  2020-05-05       Impact factor: 5.330

8.  Advances in thin tissue Golgi-Cox impregnation: fast, reliable methods for multi-assay analyses in rodent and non-human primate brain.

Authors:  Nathan D Levine; David J Rademacher; Timothy J Collier; Jennifer A O'Malley; Adrian P Kells; Waldy San Sebastian; Krystof S Bankiewicz; Kathy Steece-Collier
Journal:  J Neurosci Methods       Date:  2013-01-08       Impact factor: 2.390

9.  Chemical Control of Grafted Human PSC-Derived Neurons in a Mouse Model of Parkinson's Disease.

Authors:  Yuejun Chen; Man Xiong; Yi Dong; Alexander Haberman; Jingyuan Cao; Huisheng Liu; Wenhao Zhou; Su-Chun Zhang
Journal:  Cell Stem Cell       Date:  2016-04-28       Impact factor: 24.633

10.  Implanted reuptake-deficient or wild-type dopaminergic neurons improve ON L-dopa dyskinesias without OFF-dyskinesias in a rat model of Parkinson's disease.

Authors:  A Vinuela; P J Hallett; C Reske-Nielsen; M Patterson; T D Sotnikova; M G Caron; R R Gainetdinov; O Isacson
Journal:  Brain       Date:  2008-11-06       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.